ITFI20050041A1 - Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono - Google Patents

Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono

Info

Publication number
ITFI20050041A1
ITFI20050041A1 IT000041A ITFI20050041A ITFI20050041A1 IT FI20050041 A1 ITFI20050041 A1 IT FI20050041A1 IT 000041 A IT000041 A IT 000041A IT FI20050041 A ITFI20050041 A IT FI20050041A IT FI20050041 A1 ITFI20050041 A1 IT FI20050041A1
Authority
IT
Italy
Prior art keywords
hydroxammed
deacelitasis
istone
inhibitors
contain
Prior art date
Application number
IT000041A
Other languages
English (en)
Inventor
Andrea Piero D
Daniela Fattori
Elena Marastoni
Marina Porcelloni
Cristina Rossi
Original Assignee
Menarini Internat Operations Luxembourg Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Internat Operations Luxembourg Sa filed Critical Menarini Internat Operations Luxembourg Sa
Priority to IT000041A priority Critical patent/ITFI20050041A1/it
Priority to IT000239A priority patent/ITFI20050239A1/it
Priority to TW095107569A priority patent/TW200724529A/zh
Priority to PCT/EP2006/060687 priority patent/WO2006097460A1/en
Priority to EA200701970A priority patent/EA012909B1/ru
Priority to AU2006224624A priority patent/AU2006224624A1/en
Priority to CNA2006800066799A priority patent/CN101155780A/zh
Priority to CA002600528A priority patent/CA2600528A1/en
Priority to JP2008501287A priority patent/JP2008533091A/ja
Priority to ARP060100977A priority patent/AR058002A1/es
Priority to AP2007004188A priority patent/AP2007004188A0/xx
Priority to BRPI0606290-3A priority patent/BRPI0606290A2/pt
Priority to MX2007011072A priority patent/MX2007011072A/es
Priority to KR1020077022763A priority patent/KR20070112240A/ko
Priority to US11/886,160 priority patent/US20080207694A1/en
Priority to EP06708749A priority patent/EP1868997A1/en
Priority to SA06270135A priority patent/SA06270135B1/ar
Publication of ITFI20050041A1 publication Critical patent/ITFI20050041A1/it
Priority to IL185882A priority patent/IL185882A0/en
Priority to MA30291A priority patent/MA29389B1/fr
Priority to CR9431A priority patent/CR9431A/es
Priority to ZA200708749A priority patent/ZA200708749B/xx
Priority to CO07107399A priority patent/CO6321134A2/es
Priority to NO20075281A priority patent/NO20075281L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
IT000041A 2005-03-15 2005-03-15 Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono ITFI20050041A1 (it)

Priority Applications (23)

Application Number Priority Date Filing Date Title
IT000041A ITFI20050041A1 (it) 2005-03-15 2005-03-15 Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
IT000239A ITFI20050239A1 (it) 2005-03-15 2005-11-21 Idrossammati come inibitori dell'istone deacetilasi e formulazioni farmaceutiche che li contegono
TW095107569A TW200724529A (en) 2005-03-15 2006-03-07 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
BRPI0606290-3A BRPI0606290A2 (pt) 2005-03-15 2006-03-14 hidroxamatos como inibidores de histona desacetilase e formulações farmacêuticas os contendo
US11/886,160 US20080207694A1 (en) 2005-03-15 2006-03-14 Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them
AU2006224624A AU2006224624A1 (en) 2005-03-15 2006-03-14 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
CNA2006800066799A CN101155780A (zh) 2005-03-15 2006-03-14 作为组蛋白去乙酰基酶抑制剂的异羟肟酸盐以及含有其的药物配方
CA002600528A CA2600528A1 (en) 2005-03-15 2006-03-14 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
JP2008501287A JP2008533091A (ja) 2005-03-15 2006-03-14 ヒストンデアセチラーゼ阻害剤としてのヒドロキサム酸及びこれを含有する医薬組成物
ARP060100977A AR058002A1 (es) 2005-03-15 2006-03-14 Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen
AP2007004188A AP2007004188A0 (en) 2005-03-15 2006-03-14 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
PCT/EP2006/060687 WO2006097460A1 (en) 2005-03-15 2006-03-14 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
MX2007011072A MX2007011072A (es) 2005-03-15 2006-03-14 Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen.
KR1020077022763A KR20070112240A (ko) 2005-03-15 2006-03-14 히스톤 탈아세틸화효소 저해제로서 하이드록사메이트 및이를 함유하는 약학적 제제
EA200701970A EA012909B1 (ru) 2005-03-15 2006-03-14 Гидроксаматы как ингибиторы гистондеацетилазы и содержащие их фармацевтические композиции
EP06708749A EP1868997A1 (en) 2005-03-15 2006-03-14 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
SA06270135A SA06270135B1 (ar) 2005-03-15 2006-05-08 مركبات هيدروكسامات بصفتها مثبطات هستون دياستيلاز وتركيبات صيدلية تحتوي عليها
IL185882A IL185882A0 (en) 2005-03-15 2007-09-10 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
MA30291A MA29389B1 (fr) 2005-03-15 2007-10-11 Hydroxamates utilises en tant qu'inhibiteurs de desacetylase d'histones et formulations pharmaceutiques les contenant.
CR9431A CR9431A (es) 2005-03-15 2007-10-11 Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen
ZA200708749A ZA200708749B (en) 2005-03-15 2007-10-12 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
CO07107399A CO6321134A2 (es) 2005-03-15 2007-10-12 Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen
NO20075281A NO20075281L (no) 2005-03-15 2007-10-15 Hydroksamater som historiedeacetylasehemmere og farmasoytiske formuleringer inneholdende disse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000041A ITFI20050041A1 (it) 2005-03-15 2005-03-15 Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
IT000239A ITFI20050239A1 (it) 2005-03-15 2005-11-21 Idrossammati come inibitori dell'istone deacetilasi e formulazioni farmaceutiche che li contegono

Publications (1)

Publication Number Publication Date
ITFI20050041A1 true ITFI20050041A1 (it) 2006-09-16

Family

ID=36617217

Family Applications (2)

Application Number Title Priority Date Filing Date
IT000041A ITFI20050041A1 (it) 2005-03-15 2005-03-15 Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
IT000239A ITFI20050239A1 (it) 2005-03-15 2005-11-21 Idrossammati come inibitori dell'istone deacetilasi e formulazioni farmaceutiche che li contegono

Family Applications After (1)

Application Number Title Priority Date Filing Date
IT000239A ITFI20050239A1 (it) 2005-03-15 2005-11-21 Idrossammati come inibitori dell'istone deacetilasi e formulazioni farmaceutiche che li contegono

Country Status (22)

Country Link
US (1) US20080207694A1 (it)
EP (1) EP1868997A1 (it)
JP (1) JP2008533091A (it)
KR (1) KR20070112240A (it)
CN (1) CN101155780A (it)
AP (1) AP2007004188A0 (it)
AR (1) AR058002A1 (it)
AU (1) AU2006224624A1 (it)
BR (1) BRPI0606290A2 (it)
CA (1) CA2600528A1 (it)
CO (1) CO6321134A2 (it)
CR (1) CR9431A (it)
EA (1) EA012909B1 (it)
IL (1) IL185882A0 (it)
IT (2) ITFI20050041A1 (it)
MA (1) MA29389B1 (it)
MX (1) MX2007011072A (it)
NO (1) NO20075281L (it)
SA (1) SA06270135B1 (it)
TW (1) TW200724529A (it)
WO (1) WO2006097460A1 (it)
ZA (1) ZA200708749B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112325620A (zh) * 2020-11-13 2021-02-05 南阳中联水泥有限公司 一种水泥生产高效烘干设备

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2623034A1 (en) * 2005-09-27 2007-04-05 Novartis Ag Carboxyamine compounds and their use in the treatment of hdac dependent diseases
GB0523040D0 (en) * 2005-11-11 2005-12-21 Cyclacel Ltd Combination
CA2695452A1 (en) * 2007-08-21 2009-02-26 Arqule, Inc. Hdac inhibitors
CN102775368B (zh) 2011-05-10 2016-08-17 上海驺虞医药科技有限公司 一类噻唑类化合物及其制备方法和用途
CA3007025A1 (en) * 2015-12-22 2017-06-29 Kancera Ab Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
CA3010326C (en) * 2015-12-31 2020-07-14 Hitgen Ltd. Sulfonamide derivative and preparation method and use thereof
CN112516142B (zh) * 2020-12-11 2021-10-15 北京华氏精恒医药科技有限公司 一种具有hdac抑制活性的药物组合物、制备方法及其用途
WO2023003468A1 (en) * 2021-07-23 2023-01-26 Rijksuniversiteit Groningen Novel inhibitors of histone deacetylase (hdac), and methods, compositions and uses related thereto.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60321667D1 (en) * 2002-03-13 2008-07-31 Janssen Pharmaceutica Nv Piperazinyl-, piperidinyl- und morpholinylderivate als neue inhibitoren von histon-deacetylase
EP1492534B1 (en) * 2002-04-03 2008-06-25 TopoTarget UK Limited Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
US20040072802A1 (en) * 2002-10-09 2004-04-15 Jingwu Duan Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
WO2005004861A1 (en) * 2003-07-15 2005-01-20 Korea Research Institute Of Bioscience And Biotechnology A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
EP1685094A4 (en) * 2003-10-27 2007-08-22 S Bio Pte Ltd HYDROXAMATES CONNECTED TO ACYLUREE AND SULFONYLUREE

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112325620A (zh) * 2020-11-13 2021-02-05 南阳中联水泥有限公司 一种水泥生产高效烘干设备

Also Published As

Publication number Publication date
EA012909B1 (ru) 2010-02-26
MX2007011072A (es) 2007-10-08
MA29389B1 (fr) 2008-04-01
TW200724529A (en) 2007-07-01
US20080207694A1 (en) 2008-08-28
AU2006224624A1 (en) 2006-09-21
CR9431A (es) 2008-07-31
ZA200708749B (en) 2009-08-26
CA2600528A1 (en) 2006-09-21
KR20070112240A (ko) 2007-11-22
CN101155780A (zh) 2008-04-02
AR058002A1 (es) 2008-01-23
EA200701970A1 (ru) 2008-02-28
BRPI0606290A2 (pt) 2009-06-09
ITFI20050239A1 (it) 2007-05-22
JP2008533091A (ja) 2008-08-21
WO2006097460A8 (en) 2007-11-01
EP1868997A1 (en) 2007-12-26
CO6321134A2 (es) 2011-09-20
NO20075281L (no) 2007-10-15
WO2006097460A1 (en) 2006-09-21
SA06270135B1 (ar) 2009-07-19
AP2007004188A0 (en) 2007-10-31
IL185882A0 (en) 2008-01-06

Similar Documents

Publication Publication Date Title
ITFI20050041A1 (it) Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
CY2014011I1 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
NO20090175L (no) Stabile laquinimod sammensetninger
BRPI0511900A (pt) composições farmacêuticas
EP1765379A4 (en) CO-CRISTAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
NO20075628L (no) Farmasøytiske formuleringer
NO345139B1 (no) Florizinanaloger som inhibitorer av glukosekotransportør 2 og farmasøytisk sammensetning derav
SMT201300080B (it) Derivati di carbammati di alchiltiazoli, loro preparazione e loro utilizzo come inibitori dell'enzima faah
EP2078731A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
ITRM20080214A1 (it) Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.
ZA200900237B (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
ITMI20050730A1 (it) Preparazione di composizioni con elevata attivita'insetticida
EP1968609A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
NO20070187L (no) Oralt desintegrerende farmasoytisk preparat omfattende risperidon
ITMI20041963A1 (it) "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
NO20084860L (no) Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater
DK1957490T3 (da) Hidtil ukendte indolizinderivater, fremgangsmåde til fremstilling deraf og terapeutiske sammensætninger, der omfatter samme